Basecamp Wealth Advisors’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Other funds holding VTYX
Basecamp Wealth Advisors's VTYX Position: Q1 2026 in Review
Basecamp Wealth Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 362 shares — an estimated $3.27K sold.
Basecamp Wealth Advisors first reported a position in VTYX in Q4 2025 and held it in 1 quarter. The position peaked at $3.27K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Basecamp Wealth Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Basecamp Wealth Advisors sold 362 Ventyx Biosciences shares in Q1 2026, an estimated $3.27K.
- Basecamp Wealth Advisors first reported a position in Ventyx Biosciences in Q4 2025 and held it in 1 quarter.
- Basecamp Wealth Advisors's Ventyx Biosciences position peaked at $3.27K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q1 2026, filed 24 Jun 2026.